Can Non-Pharmacological Treatment Promote Additional Benefit for Children with Familial Hypercholesterolemia Treated with Statins?

Arq Bras Cardiol. 2018 Dec;111(6):822-823. doi: 10.5935/abc.20180235.
[Article in English, Portuguese]
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Child
  • Cholesterol, LDL
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Hyperlipoproteinemia Type II*

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors